Please reload

Recent Posts

CreaGen & C2I's CEO/Co-founder Recieves 2018 Henry A. Hill Award

November 26, 2018

1/5
Please reload

Featured Posts

Welcome IM Therapeutics to the C2I Family!

October 17, 2019

 

We would love to extend our warm welcome to IM Therapeutics! 

 

IM Therapeutics is redefining autoimmunity and transforming lives by building novel personalized medicines for autoimmune diseases with a first-of-its-kind targeted drug design and patient-centered approach. Their novel therapies specifically block the action of HLA proteins known to be involved in the triggering of an autoimmune response. 

 

To learn more, visit their website: https://www.imtherapeutics.com/

Please reload

Follow Us